Kewaunee Scientific Expands Reach with Nu Aire Acquisition
Kewaunee Scientific Expands Reach with Nu Aire Acquisition
Kewaunee Scientific Corporation, a leader in quality laboratory and healthcare products, has successfully completed its acquisition of Nu Aire, a Minneapolis-based manufacturer known for its range of laboratory and pharmacy equipment. This $55 million deal, spearheaded by Carl Marks Securities, signals a significant shift in Kewaunee's corporate strategy aimed at expanding its market presence.
The Significance of the Acquisition
The addition of Nu Aire to Kewaunee’s portfolio is considered transformative, as it enhances their distribution capabilities globally. The synergy between the two companies is notable; Nu Aire brings to the table a well-regarded reputation and a diversified product lineup that complements Kewaunee's offerings.
Strategic Benefits for Kewaunee
This acquisition allows Kewaunee to enrich its existing product line and appeals to a wider client base in various sectors including life sciences and healthcare. As the demand for laboratory equipment grows, Kewaunee is well-positioned to meet these emerging needs effectively.
Company Background: Kewaunee Scientific
Kewaunee Scientific Corporation, established in 1906 and headquartered in Statesville, North Carolina, specializes in designing and manufacturing furnishings for laboratories and healthcare environments. Their extensive product range includes steel and wood casework, fume hoods, moveable workstations, and various safety equipment.
A Legacy of Excellence
Kewaunee’s heritage of over a century in the industry lends to their expertise and credibility, making them a trusted partner in laboratory furnishing solutions. With manufacturing facilities in both the U.S. and India, they cater to a global market, signifying their robust manufacturing capabilities.
Nu Aire: A Complementary Partner
Founded in 1971, Nu Aire is recognized for its innovate solutions in laboratory and pharmacy environments. The company has established itself as a leader in producing crucial laboratory equipment such as biological safety cabinets and airflow products. They play a pivotal role in ensuring safety and quality across varied laboratory sectors.
Enhancing Product Offerings
The integration of Nu Aire’s extensive product offerings aligns well with Kewaunee's goals, enhancing both companies' ability to serve the laboratory sector effectively. The acquisition allows Kewaunee to offer a more comprehensive suite of solutions to its clients.
Leadership Insights
Chris Parisi, a Partner at Carl Marks Advisors, emphasized the transformative nature of this acquisition. By combining resources, both Kewaunee and Nu Aire are equipped to capitalize on the growing investments in life sciences and healthcare globally.
Evan Tomaskovic, Managing Partner at Carl Marks Advisors, shared insights on the long-standing advisory relationship with Kewaunee and their role in this significant acquisition. He noted, "Assisting a century-old institution in acquiring a 50-year-old family-owned business is gratifying, which solidifies the legacy of both companies.”
Gratitude and Future Plans
Thomas D. Hull III, President and CEO of Kewaunee, expressed appreciation for Carl Marks Securities for their leadership during the acquisition process. He commended the firm for their valuable insights that guided Kewaunee in forging a stronger partnership with Nu Aire.
Don Gardner, CFO at Kewaunee, reiterated that the acquisition is a strategic move designed to bolster their competitive position in the marketplace. The collaboration with Carl Marks Securities was essential in navigating the complexities of this deal.
About Kewaunee Scientific
Kewaunee Scientific continues to lead in innovation in the design and manufacture of laboratory and healthcare products. With a strong infrastructure, including multiple manufacturing facilities, they maintain a global presence across several markets.
Frequently Asked Questions
What prompted the acquisition of Nu Aire by Kewaunee Scientific?
The acquisition was driven by Kewaunee's strategy to expand its market reach and enhance the product offerings available to clients in laboratory settings.
How long has Kewaunee been in the industry?
Kewaunee Scientific Corporation has a long history spanning over 100 years, having been founded in 1906.
What type of products does Nu Aire manufacture?
Nu Aire specializes in laboratory equipment, including biological safety cabinets, CO2 incubators, and airflow products, catering to various laboratory environments.
What are the benefits of this acquisition for customers?
This acquisition allows customers to access a broader selection of high-quality laboratory products and solutions while benefiting from enhanced support and distribution capabilities.
How does this acquisition align with industry trends?
The acquisition positions Kewaunee to capitalize on the growing investment in life sciences and healthcare, meeting increasing demands for modern laboratory solutions.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
